Sign in or register to see full information and data.

Studies / CAVD 376


Study information

Grant Affiliation:Haynes: B-Cell Lineage Envelope Design
Strategy:Prophylactic neutralizing Ab
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2012-07-20
Study Made Public:2016-02-16


Neutralization of plasma and recombinant mAbs from RV144/RV305 patients


CAVD 376 is an immunogenicity study to screen monoclonal antibodies from vaccine recipients in the human clinical trials, RV144, RV305, and RV306.


ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.